Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Eyelid oedema | Eyelid oedema | 2.8% | x | x | |
| Punctate keratitis | Punctate keratitis | 2% | x | ||
| Superficial punctate keratopathy | x | ||||
| Hyperaemia | Hyperaemia | x | |||
| Hypersensitivity | Hypersensitivity | x | |||
| Nausea | Nausea | x | |||
| Intraocular pressure increased | Intraocular pressure increased | x | x | ||
| Keratopathy | Keratopathy | x | |||
| Vision blurred | Vision blurred | x | |||
| Corneal oedema | Corneal stromal edema | x | x | ||
| Pain | Stinging | x | |||
| Dry eye | Keratitis sicca | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |